Chu Haiyan
1. Personal Information
Title/Position: Lecturer
Correspondence Address:Department of Occupational Medicine and Environmental Health, Nanjing Medical University, 101 Longmian Av., Jiangning District, Nanjing, Jiangsu Province, 211166, P.R. China.
Telephone: 86-25-8686-8420
E-mail: chygrape@njmu.edu.cn
2. Education
INSTITUTION | DEGREE (if applicable) | MM/YY | FIELD OF STUDY |
Nanjing Medical University | BS | 07/09 | Preventive Medicine |
Nanjing Medical University | Ph.D. | 07/14 | Public Health and Preventive Medicine |
3. Research Interests
I am currently conducting research in two areas: (1) Air pollution and human health; (2) genetic and epigenetic mechanisms in human cancers.
4. Selected Publications
(1)Chu H, Zhong D, Tang J, Li J, Xue Y, Tong N, Qin C, Yin C, Zhang Z, Wang M. A functional variant in miR-143 promoter contributes to prostate cancer risk.Arch Toxicol. 2016 Feb; 90(2):403-14.
(2)Chu H, Hui G, Yuan L, Shi D, Wang Y, Du M, Zhong D, Ma L, Tong N, Qin C, Yin C, Zhang Z, Wang M. Identification of novel piRNAs in bladder cancer.Cancer Lett. 2015 Jan 28; 356(2 Pt B):561-7.
(3)Chu H, Xia L, Qiu X, Gu D, Zhu L, Jin J, Hui G, Hua Q, Du M, Tong N, Chen J, Zhang Z, Wang M. Genetic variants in noncoding PIWI-interacting RNA and colorectal cancer risk.Cancer. 2015 Jun 15; 121(12):2044-52.
(4)Chu H, Wang, Yan F, Zhong D, Shi D, Ma L, Pan X, Qin C, Yin C, and Zhang Z . Polymorphisms in the IL-13 and IL-4R genes are associated with the development of renal cell carcinoma. Ann Oncol. 2012 Aug;23(8):2114-21
(5)Wang M#, Li Z#, Chu H#(Co-first), Lv Q#, Ye D#, Ding Q#, Xu C, Guo J, Du M, Chen J, Song Z, Yin C, Qin C, Gu C, Zhu Y, Xia G, Liu F, Zhang Z, Yuan L, Fu G, Hu Z, Tong N, Shen J, Liu K, Sun J, Sun Y, Li J, Li X, Shen H, Xu J, Shi Y, Zhang Z. Genome-Wide Association Study of Bladder Cancer in a Chinese Cohort Reveals a New Susceptibility Locus at 5q12.3. Cancer Res. 2016 Jun 1;76(11):3277-84.
(6)Wang M#, Chu H#(Co-first), Li P#, Yuan L, Fu G, Ma L, Shi D, Zhong D, Tong N, Qin C, Yin C, Zhang Z. Genetic variants in microRNAs predict bladder cancer risk and recurrence. Cancer Res. 2012 Dec 1; 72(23): 6173-82.
